Preliminary results of a phase 2 trial of obinutuzumab, in combination with ifosfamide, carboplatin and etoposide (oice) in children, adolescents andyoung adults with relapsed/refractory mature b-cell non-hodgkin lymphoma
Leukemia Research(2022)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要